BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26420370)

  • 1. Incidental Diagnosis of Asymptomatic Non-Small-Cell Lung Cancer: A Registry-Based Analysis.
    Kocher F; Lunger F; Seeber A; Amann A; Pircher A; Hilbe W; Fiegl M
    Clin Lung Cancer; 2016 Jan; 17(1):62-7.e1. PubMed ID: 26420370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies.
    Ou SH; Zell JA
    J Thorac Oncol; 2009 Oct; 4(10):1202-11. PubMed ID: 19701111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of incidentally detected lung cancers.
    Quadrelli S; Lyons G; Colt H; Chimondeguy D; Buero A
    Int J Surg Oncol; 2015; 2015():287604. PubMed ID: 25685550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological characteristics of screen-detected lung cancers.
    Kawachi R; Watanabe S; Asamura H
    J Thorac Oncol; 2009 May; 4(5):615-9. PubMed ID: 19318993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of patients with lung cancer detected incidentally.
    Kanashiki M; Satoh H; Ishikawa H; Ohtsuka M; Sekizawa K
    Oncol Rep; 2004 Oct; 12(4):945-8. PubMed ID: 15375527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
    Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
    Kogure Y; Ando M; Saka H; Chiba Y; Yamamoto N; Asami K; Hirashima T; Seto T; Nagase S; Otsuka K; Yanagihara K; Takeda K; Okamoto I; Aoki T; Takayama K; Yamasaki M; Kudoh S; Katakami N; Miyazaki M; Nakagawa K
    J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors.
    Chen KY; Chen JH; Shih JY; Yang CH; Yu CJ; Yang PC
    J Thorac Oncol; 2010 Jan; 5(1):82-9. PubMed ID: 19884854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old: a population-based study.
    Liu M; Cai X; Yu W; Lv C; Fu X
    Oncotarget; 2015 Dec; 6(42):44963-70. PubMed ID: 26517681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical model to estimate recurrence risk in resected stage I non-small cell lung cancer.
    Goodgame B; Viswanathan A; Miller CR; Gao F; Meyers B; Battafarano RJ; Patterson A; Cooper J; Guthrie TJ; Bradley J; Pillot G; Govindan R
    Am J Clin Oncol; 2008 Feb; 31(1):22-8. PubMed ID: 18376223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
    Kocher F; Hilbe W; Seeber A; Pircher A; Schmid T; Greil R; Auberger J; Nevinny-Stickel M; Sterlacci W; Tzankov A; Jamnig H; Kohler K; Zabernigg A; Frötscher J; Oberaigner W; Fiegl M
    Lung Cancer; 2015 Feb; 87(2):193-200. PubMed ID: 25564398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.
    Risteski M; Crvenkova S; Atanasov Z; Isjanovska R
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):49-61. PubMed ID: 24566015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
    Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
    Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
    Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
    J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.
    Giroux Leprieur E; Labrune S; Giraud V; Gendry T; Cobarzan D; Chinet T
    Clin Lung Cancer; 2012 Sep; 13(5):363-8. PubMed ID: 22264658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival.
    Mutlu H; Buyukcelik A; Erden A; Aslan T; Akca Z; Kaya E; Kibar M; Seyrek E; Yavuz S; Calikusu Z
    Asian Pac J Cancer Prev; 2013; 14(6):3743-6. PubMed ID: 23886175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.